Chan A M AM - OmicsDI

Show results for

Unknown (1672)
Proteomics (26)
Transcriptomics (25)
Genomics (19)
Metabolomics (3)

Organisms

Homo sapiens (48)
Mus musculus (7)
Arabidopsis thaliana (4)
Chlamydomonas reinhardtii (3)
Danio rerio (2)
Ancylostoma ceylanicum (2)
Plasmodium (1)
Plasmodium falciparum 3D7 (1)

Repository

biostudies-arrayexpress (27)
pride (23)
EGA (17)
MetaboLights (3)
MassIVE (2)
jPOST (1)

Tissue

Epithelial cell (2)
Blood serum (1)
Brain (1)
Breast cancer cell (1)
Cell culture (1)
Cilium (1)
HEK-293T cell (1)
Hepatocyte (1)
Jejunum (1)
Kidney (1)
Liver (1)
Stem cell (1)
Whole body (1)

Disease

Age related macular degeneration (1)
Breast cancer (1)
Developmental and epileptic encephalopathy 2 (1)
Immune system disease (1)
Neurodevelopmental abnormality (1)
Plasmodium falciparum malaria (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (23)
Bottom-up proteomics (8)
Shotgun proteomics (7)
Affinity purification coupled with mass spectrometry proteomics (4)
Mass spectrometry (3)
Data-dependent acquisition (3)
Illumina HiSeq 2500, ILLUMINA (1)
Data-independent acquisition (1)
Gel-based experiment (1)
SRM/MRM (1)
Top-down proteomics (1)

Instrument Platform

Illumina HiSeq 2500 (2)
Orbitrap Fusion Lumos (2)
Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Agilent NGS Workstation (1)
Orbitrap Eclipse (1)
Direct infusion MS - negative (1)
Direct infusion MS - positive (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - negative - hilic (1)

Publication Date

2013 (8)
2025 (8)
2010 (7)
2024 (7)
2022 (4)
2014 (3)
2012 (3)
2011 (3)
2026 (3)
2023 (3)
2018 (3)
2020 (2)
2015 (1)
2021 (1)

CHEBI ID

CHEBI:64525 (2)
CHEBI:64569 (2)
CHEBI:131439 (1)
CHEBI:131739 (1)
CHEBI:131740 (1)
CHEBI:132004 (1)
CHEBI:132007 (1)
CHEBI:132502 (1)
CHEBI:132538 (1)
CHEBI:132539 (1)
CHEBI:132540 (1)
CHEBI:132543 (1)
CHEBI:132544 (1)
CHEBI:132591 (1)
CHEBI:132676 (1)
CHEBI:132677 (1)
CHEBI:133629 (1)
CHEBI:134239 (1)
CHEBI:134241 (1)
CHEBI:134242 (1)
CHEBI:134243 (1)
CHEBI:134264 (1)
CHEBI:134270 (1)
CHEBI:134271 (1)
CHEBI:134428 (1)
CHEBI:134429 (1)
CHEBI:134439 (1)
CHEBI:134451 (1)
CHEBI:134460 (1)
CHEBI:134487 (1)

Metabolite Name

Acylcarnitine (C10-OH) (1)
Acylcarnitine (C4-Methyl) (1)
Acylcarnitine (C4-Methyl-OH) (1)
Acylcarnitine 10:0 (1)
Acylcarnitine 14:0 (1)
Acylcarnitine 16:0 (1)
Acylcarnitine 18:0 (1)
Acylcarnitine 18:2 (1)
Acylcarnitine 20:0 (1)
Acylcarnitine 2:0 (1)
Acylcarnitine 3:0 (1)
Acylcarnitine 4:0 (1)
Acylcarnitine 5:0 (1)
Acylcarnitine 6:0 (1)
Acylcarnitine 8:0 (1)
CE 14:0 (1)
CE 16:0 (1)
CE 16:1 (1)
CE 16:2 (1)
CE 17:0 (1)
CE 17:1 (1)
CE 18:0 (1)
CE 18:1 (1)
CE 18:2 (1)
CE 18:3 (1)
CE 20:0 (1)
CE 20:2 (1)
CE 20:3 (1)
CE 20:4 (1)
CE 20:5 (1)

Modification

N6 (1)
N6-dimethyl-L-lysine (1)

Study type

Transcription profiling by array (12)
Unknown experiment type (4)
RNA-seq of coding RNA (4)
Comparative genomic hybridization by array (3)
DNA-seq (2)
Genotyping by array (1)
MicroRNA profiling by high throughput sequencing (1)

Release Date

2024 (212)
2023 (212)
2022 (202)
2025 (191)
2021 (188)
2020 (165)
2018 (118)
2019 (81)
2017 (64)
2016 (59)
2015 (46)
2013 (33)
2014 (29)
2011 (22)
2010 (20)
2012 (17)
2026 (17)
2008 (8)
2009 (7)
2007 (3)
2006 (3)
2004 (1)
1998 (1)

Lab affiliation

Indiana University School of Medicine (2)
Program in Molecular Medicine, UMass Chan Medical School (2)
Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605-2377, USA (2)
1Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA (1)
1Nutrient Metabolism & Signalling Laboratory, Metabolism, Diabetes and Obesity Program, Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia. 2Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University, Victoria 3800, Australia. (1)
Associate Professor of Oncological Sciences Huntsman Cancer Institute at the University of Utah (1)
Centre of New Technologies, University of Warsaw, S. Banacha 2c, 02-097 Warsaw, Poland (1)
Dana Farber Cancer Institute (1)
Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver BC, Canada (1)
Department of Biochemistry, Albert Einstein College of Medicine (1)
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA (1)
Ichan School of Medicine at Mount Sinai (1)
Institute of Biomaterials and Biomedical Engineering, Department of Chemical Engineering, Department of Chemistry, Department of Materials Science and Engineering, University of Toronto, 164 College Street, Toronto, Ontario M5S 3G9, Canada. Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, Ontario, M5S 3E1, Canada. (1)
Program in Molecular Medicine UMass Chan Medical School Worcester MA 01605 USA (1)
School of Biomedical Science, The Chinese University of Hong Kong (1)
School of Life Sciences, The Chinese University of Hong Kong, Sha Tin, N.T., Hong Kong; State Key Laboratory of Agrobiotechnology, and School of Life Sciences, The Chinese University of Hong Kong, Shatin N.T., Hong Kong (1)
The Center for Chemical Biology, Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (1)
The University of Melbourne (1)
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia (1)
Toronto General Hospital Research Institute, UniversityHealth Network, Toronto, Canada Department of Medicine, Division of Nephrology, University Health Network, Toronto, Canada (1)

Previous page
1 / 175
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 175
Next page

Sort by:

Relevance

Page size

Targeting the SREBP-dependent lipidomic reprogramming by virus infection for broad-spectrum therapeutic intervention

Viruses are obligate intracellular parasites that exploit the host metabolic machineries to meet their extraordinary biosynthetic demands. Integrative transcriptomic and lipidomic profiling confirmed that Middle East respiratory syndrome coronavirus (MERS-CoV) infection reprograms the host lipid met...

2018-11-26 | MTBLS762 | MetaboLights

Identification of a Polymorphism in the N Gene of SARS-CoV-2 That Adversely Impacts Detection by Reverse Transcription-PCR.

Not available

S-EPMC7771441 | biostudies-literature

Characterization of R-ras3/m-ras null mice reveals a potential role in trophic factor signaling.

Not available

S-EPMC1592885 | biostudies-literature

Gene expression signatures for human iPSC and ESC lines

In comprehensive glycome analysis with a high-density lectin microarray, we have previously shown that the recombinant N-terminal domain of the lectin BC2L-C from Burkholderia cenocepacia (rBC2LCN) binds exclusively to undifferentiated human induced pluripotent stem (iPS) cells and embryonic stem (E...

ORGANISM(S): Homo sapiens

2015-10-28 | E-GEOD-42099 | biostudies-arrayexpress

The microbiota of pregnant women with SARS-CoV-2 and their infants.

Not available

S-EPMC10291758 | biostudies-literature

Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.

Not available

S-EPMC7447618 | biostudies-literature

Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan.

Not available

S-EPMC10619501 | biostudies-literature

Discovery of Clonixeril as a Sub-Femtomolar Modulator of the Human STING Receptor.

Not available

S-EPMC12203428 | biostudies-literature

LF2 phosphorylation of the CDKL5 activation loop controls CDKL5’s activity

Cdkl5 Deficiency Disorder (CDD) is caused by variants in the protein kinase CDKL5, leading to symptoms such as seizures, developmental delay, and severe intellectual disability. The Chlamydomonas homologue of human CDKL5 is the flagellar protein LF5, whose absence results in a long flagella phenotyp...

ORGANISM(S): Chlamydomonas reinhardtii

2025-11-15 | PXD068782 | Pride

Capsular glycan recognition provides antibody-mediated immunity against tuberculosis.

Not available

S-EPMC7108924 | biostudies-literature

Previous page
1 / 175
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 175
Next page

Sort by:

Relevance

Page size

1745 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Modification

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets